标题
Therapeutic targeting of IL-6 trans-signaling
作者
关键词
Cytokine, Cytokine receptor, Interleukin-6, GP130, Trans-signaling, Soluble receptor, blood-buffer
出版物
CYTOKINE
Volume 144, Issue -, Pages 155577
出版商
Elsevier BV
发表日期
2021-05-19
DOI
10.1016/j.cyto.2021.155577
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Transneuronal delivery of hyper-interleukin-6 enables functional recovery after severe spinal cord injury in mice
- (2021) Marco Leibinger et al. Nature Communications
- Control of RNA Stability in Immunity
- (2021) Shizuo Akira et al. Annual Review of Immunology
- Therapeutic IL-6 trans-signalling inhibition by olamkicept (sgp130Fc) in patients with active inflammatory bowel disease
- (2021) Stefan Schreiber et al. GASTROENTEROLOGY
- Natural Glycoforms of Human Interleukin 6 Show Atypical Plasma Clearance
- (2021) Andreas Reif et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Repopulating Microglia Promote Brain Repair in an IL-6-Dependent Manner
- (2020) Emily F. Willis et al. CELL
- Biological functions and therapeutic opportunities of soluble cytokine receptors
- (2020) Juliane Lokau et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome
- (2020) Vivien Béziat et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy
- (2020) Ting Zhou et al. NATURE
- Cathepsin S provokes interleukin-6 (IL-6) trans-signaling through cleavage of the IL-6 receptor in vitro
- (2020) Charlotte M. Flynn et al. Scientific Reports
- Enhanced IL-36R signaling promotes barrier impairment and inflammation in skin and intestine
- (2020) Zaruhi Hovhannisyan et al. Science Immunology
- ADAM17 selectively activates the IL‐6 trans‐signaling/ERK MAPK axis in KRAS‐addicted lung cancer
- (2019) Mohamed I Saad et al. EMBO Molecular Medicine
- Targeting Interleukin-6 Signaling in Clinic
- (2019) Sujin Kang et al. IMMUNITY
- The IL-6-neutralizing sIL-6R/sgp130 buffer system is disturbed in patients with type 2 diabetes
- (2019) Samadhi Aparicio-Siegmund et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses
- (2019) Sarah Spencer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- ADAM17 Activity and IL-6 Trans-Signaling in Inflammation and Cancer
- (2019) Schumacher et al. Cancers
- ADAM17 is required for EGF-R–induced intestinal tumors via IL-6 trans-signaling
- (2018) Stefanie Schmidt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Interleukin-6: designing specific therapeutics for a complex cytokine
- (2018) Christoph Garbers et al. NATURE REVIEWS DRUG DISCOVERY
- The role of IL-6 in host defence against infections: immunobiology and clinical implications
- (2017) Stefan Rose-John et al. Nature Reviews Rheumatology
- Interleukin-6 Family Cytokines
- (2017) Stefan Rose-John Cold Spring Harbor Perspectives in Biology
- Proteolytic Origin of the Soluble Human IL-6R In Vivo and a Decisive Role of N-Glycosylation
- (2017) Steffen Riethmueller et al. PLOS BIOLOGY
- Meprin Metalloproteases Generate Biologically Active Soluble Interleukin-6 Receptor to Induce Trans-Signaling
- (2017) Philipp Arnold et al. Scientific Reports
- Quantitative proteomics screen identifies a substrate repertoire of rhomboid protease RHBDL2 in human cells and implicates it in epithelial homeostasis
- (2017) Nicholas Johnson et al. Scientific Reports
- Therapeutic Targeting of the IL-6 Trans-Signaling/Mechanistic Target of Rapamycin Complex 1 Axis in Pulmonary Emphysema
- (2016) Saleela M. Ruwanpura et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trial
- (2016) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-6 trans-signaling is essential for the development of hepatocellular carcinoma in mice
- (2016) Juri Bergmann et al. HEPATOLOGY
- A pathogenic role for T cell–derived IL-22BP in inflammatory bowel disease
- (2016) Penelope Pelczar et al. SCIENCE
- Insights into Cytokine–Receptor Interactions from Cytokine Engineering
- (2015) Jamie B. Spangler et al. Annual Review of Immunology
- Blocking IL-6 trans-Signaling Prevents High-Fat Diet-Induced Adipose Tissue Macrophage Recruitment but Does Not Improve Insulin Resistance
- (2015) Michael J. Kraakman et al. Cell Metabolism
- The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition
- (2015) Christoph Garbers et al. CURRENT OPINION IN IMMUNOLOGY
- Shedding of Endogenous Interleukin-6 Receptor (IL-6R) Is Governed by A Disintegrin and Metalloproteinase (ADAM) Proteases while a Full-length IL-6R Isoform Localizes to Circulating Microvesicles
- (2015) Neele Schumacher et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- IL-6 Trans-Signaling Drives Murine Crescentic GN
- (2015) G. S. Braun et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- IL-6 as a keystone cytokine in health and disease
- (2015) Christopher A Hunter et al. NATURE IMMUNOLOGY
- Systematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in rheumatoid arthritis clinical trials
- (2015) Vibeke Strand et al. ARTHRITIS RESEARCH & THERAPY
- The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases
- (2014) Christoph Garbers et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Therapeutic Targeting of IL-6 Trans Signaling Counteracts STAT3 Control of Experimental Inflammatory Arthritis
- (2014) M. A. Nowell et al. JOURNAL OF IMMUNOLOGY
- IL-6 in Inflammation, Immunity, and Disease
- (2014) T. Tanaka et al. Cold Spring Harbor Perspectives in Biology
- Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial
- (2013) Cem Gabay et al. LANCET
- New targets for mucosal healing and therapy in inflammatory bowel diseases
- (2013) M F Neurath Mucosal Immunology
- Arid5a controls IL-6 mRNA stability, which contributes to elevation of IL-6 level in vivo
- (2013) Kazuya Masuda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Functional IL6R 358Ala Allele Impairs Classical IL-6 Receptor Signaling and Influences Risk of Diverse Inflammatory Diseases
- (2013) Ricardo C. Ferreira et al. PLoS Genetics
- Therapeutic targeting of interleukin-6 trans-signaling does not affect the outcome of experimental tuberculosis
- (2012) Jan Sodenkamp et al. IMMUNOBIOLOGY
- IL-6 Controls the Innate Immune Response against Listeria monocytogenes via Classical IL-6 Signaling
- (2012) J. Hoge et al. JOURNAL OF IMMUNOLOGY
- The interleukin 6 pathway and atherosclerosis
- (2012) Jürgen Scheller et al. LANCET
- Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
- (2012) LANCET
- Transsignaling of Interleukin-6 Crucially Contributes to Atherosclerosis in Mice
- (2011) Harald Schuett et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer
- (2011) Marina Lesina et al. CANCER CELL
- Selective blockade of interleukin-6 trans-signaling improves survival in a murine polymicrobial sepsis model*
- (2011) Tanja Barkhausen et al. CRITICAL CARE MEDICINE
- Species Specificity of ADAM10 and ADAM17 Proteins in Interleukin-6 (IL-6) Trans-signaling and Novel Role of ADAM10 in Inducible IL-6 Receptor Shedding
- (2011) Christoph Garbers et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of Classic Signaling Is a Novel Function of Soluble Glycoprotein 130 (sgp130), Which Is Controlled by the Ratio of Interleukin 6 and Soluble Interleukin 6 Receptor
- (2011) Christoph Garbers et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Interleukin-36–Receptor Antagonist Deficiency and Generalized Pustular Psoriasis
- (2011) Slaheddine Marrakchi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Insulin-sensitive obesity
- (2010) Nora Klöting et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The soluble Interleukin 6 receptor: Generation and role in inflammation and cancer
- (2010) Athena Chalaris et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- IL-6 Trans-Signaling Modulates TLR4-Dependent Inflammatory Responses via STAT3
- (2010) C. J. Greenhill et al. JOURNAL OF IMMUNOLOGY
- IL-1 family nomenclature
- (2010) Charles Dinarello et al. NATURE IMMUNOLOGY
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
- (2009) Sergei Grivennikov et al. CANCER CELL
- Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay
- (2009) Kazufumi Matsushita et al. NATURE
- Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease
- (2008) N. Nishimoto et al. BLOOD
- Structure-guided Optimization of the Interleukin-6 Trans-signaling Antagonist sgp130
- (2008) Stephanie Tenhumberg et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structural Biology of Shared Cytokine Receptors
- (2007) Xinquan Wang et al. Annual Review of Immunology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started